Affordable Access

Publisher Website

The Maudsley Bipolar Disorder Project: Executive Dysfunction in Bipolar Disorder I and Its Clinical Correlates

Authors
Journal
Biological Psychiatry
0006-3223
Publisher
Elsevier
Publication Date
Volume
58
Issue
11
Identifiers
DOI: 10.1016/j.biopsych.2005.04.056
Keywords
  • Bipolar Disorder
  • Cognition
  • Medication
  • Duration Of Illness
Disciplines
  • Law

Abstract

Background Cognitive abnormalities are increasingly recognized as a feature of bipolar I disorder (BDI,) but there is limited information regarding the pattern and severity of cognitive impairment during remission and its relationship with clinical variables. Methods Forty-four remitted BDI patients recruited from a representative treatment sample and an equal number of matched healthy volunteers underwent comprehensive clinical and cognitive assessments. Cognitive evaluation covered the domains of IQ, memory, and executive function. The profile of cognitive deficits in patients was examined, and the correlation of executive function with clinical features and treatment variables was explored. Results Remitted BDI patients were impaired in tests of executive function compared with healthy participants. Within the patient group, current antipsychotic treatment predicted worse performance across all executive function tests, whereas duration of illness predicted loss of inhibitory control. Residual mood symptoms, regardless of polarity, had a negative impact primarily on measures of attentional interference. Conclusions These results suggest that impaired executive function might be an important feature of BDI. Antipsychotic treatment, duration of illness, and level of symptoms are the most significant contributors to the observed impairment.

There are no comments yet on this publication. Be the first to share your thoughts.